A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 75.50
+1.80 (2.44%)
Oct 8, 2026, 1:30 PM CST
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.57 billion as of October 8, 2026. It is the 27,029th most valuable company in the world and the 1,523rd biggest in Taiwan. Its market cap has decreased by 16.86% in one year.
Market Cap
2.57B
Enterprise Value
2.26B
Revenue
887.93M
Global Rank
Country Rank
#1,523 Taiwan
PE Ratio
13.65
ChartMarket Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.57B, an increase of 68.84%. That is a compound annual growth rate of 14.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.57B | -12.97% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.32B |
| Apex Biotechnology | 3.05B |
| Bonraybio | 2.83B |
| Applied BioCode | 2.75B |
| Wellell | 2.45B |
| Medimaging Integrated Solution | 2.25B |
| Dynamic Medical Technologies | 2.15B |
| OK Biotech | 1.95B |